title: Quality of Life is Similar between Long-term Survivors of Indolent and Aggressive Non-Hodgkin Lymphoma.
abstract: Differences in quality of life (QOL) of long-term survivors of aggressive or indolent subtypes of non-Hodgkin lymphoma (NHL) have not been frequently evaluated. We assessed these differences by analyzing results of a large QOL survey of long-term NHL survivors. We hypothesized that the incurable nature of indolent NHL would relate to worse QOL in long-term survivors while the potentially cured long-term survivors of aggressive lymphoma would have better QOL. We found that QOL was similar between the two groups. Results suggest that patients with indolent NHL are coping well with their disease, yet experience some overall feelings of life threat.
authors.affiliation: a Div. of Hematologic Malignancy and Cellular Therapy , Duke University Medical Center Durham , NC , USA.
authors.forename: Anne W
authors.initials: AW
authors.lastname: Beaven
authors.affiliation: b Department of Biostatistics and Bioinformatics , Duke University Medical Center , Durham , NC , USA.
authors.forename: Greg
authors.initials: G
authors.lastname: Samsa
authors.affiliation: c Cecil G. Sheps Center for Health Services Research and the School of Social Work , University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.
authors.forename: Sheryl
authors.initials: S
authors.lastname: Zimmerman
authors.affiliation: d Duke University School of Nursing , Durham , NC , USA.|e Duke Cancer Institute , Durham , NC , USA.
authors.forename: Sophia K
authors.initials: SK
authors.lastname: Smith
mesh_terms: D003131:Combined Modality Therapy; D003430:Cross-Sectional Studies; D018450:Disease Progression; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D008297:Male; D009367:Neoplasm Staging; D063868:Patient Outcome Assessment; D011159:Population Surveillance; D011788:Quality of Life; D012959:Socioeconomic Factors; D017741:Survivors
keywords: Quality of Life; aggressive; indolent; non-Hodgkin lymphoma